Phibro Animal Health (PAHC) Cash & Current Investments (2013 - 2026)

Phibro Animal Health's Cash & Current Investments history runs 14 years deep, the most recent figure standing at $77.5 million for Q1 2026.

• In Q1 2026, Cash & Current Investments rose 10.09% year-over-year to $77.5 million; the TTM figure through Mar 2026 stood at $77.5 million (up 10.09% YoY), while the FY2025 annual figure was $77.0 million, down 32.78% from the prior year.
• Cash & Current Investments was $77.5 million for Q1 2026 at Phibro Animal Health, up from $74.5 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $114.6 million in Q2 2024 to a low of $67.1 million in Q4 2024.
• Historically, Cash & Current Investments has averaged $84.6 million across 5 years, with a median of $85.3 million in 2025.
• The sharpest annual moves came in 2024 and 2025: Cash & Current Investments jumped 41.01% in 2024, then tumbled 32.78% in 2025.
• A 5-year view of Cash & Current Investments shows it stood at $78.4 million in 2022, then rose by 17.94% to $92.5 million in 2023, then dropped by 27.48% to $67.1 million in 2024, then increased by 11.08% to $74.5 million in 2025, then rose by 3.95% to $77.5 million in 2026.
• The last three Cash & Current Investments figures came in at $77.5 million (Q1 2026), $74.5 million (Q4 2025), and $85.3 million (Q3 2025), per Business Quant data.